What is ARS Pharmaceuticals, Inc.'s total revenue?

ARS Pharmaceuticals, Inc. (SPRY) reported total revenue of $22.68M in Q1 2026.

How has ARS Pharmaceuticals, Inc.'s total revenue changed year-over-year?

ARS Pharmaceuticals, Inc.'s total revenue increased by 184.5% year-over-year, from $7.97M to $22.68M.

What is the long-term trend for ARS Pharmaceuticals, Inc.'s total revenue?

Over 4 years (2021 to 2025), ARS Pharmaceuticals, Inc.'s total revenue has grown at a 97.8% compound annual growth rate (CAGR), from $5.51M to $84.28M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

ARS Pharmaceuticals, Inc. SPRY Total Revenue

Total Revenue at other companies

Amneal Pharmaceuticals, Inc.AMRX

$722.52M+3.9%

ViatrisVTRS

$3.52B+8.1%

AMP

Amphastar PharmaceuticalsAMPH

$171.17M+0.4%

Catalyst PharmaceuticalCPRX

$149.39M+5.6%

Eton Pharmaceuticals, Inc.ETON

$24.27M+40.4%

Segments

By product

See full

Revenue Under Collaboration Agreements$210K—

Revenue Under Supply Agreements$0—

By geography

See full

Non Us$2.45M—

Other financials

Income statement

See full

Operating income-$60.1M-61.8%

Net income-$60.6M-78.6%

EPS (diluted)-$0.61-74.3%

Balance sheet

See full

Cash & equivalents$24.3M-39.0%

Total debt$96.5M+132,122%

Total equity$61.3M-73.2%

Total assets$287.6M-12.1%

Cash flow

See full

Operating cash flow-$44.9M-10.3%

CapEx--100%

Free cash flow-$44.9M-10.1%

Valuation

See full

Market cap$1.05B-32.6%

Enterprise value$1.12B-26.0%

P/S10.6×-5.4×

Profitability

See full

Operating margin-204.5%—

Net margin-200%-219pp

FCF margin-177.1%-206pp

Returns & leverage

See full

Return on equity-136.4%-144pp

Debt / equity1.6×+1.6×

Current ratio4.9×-6.1×

Where this comes from

Reported directly by ARS Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about ARS Pharmaceuticals, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ARS Pharmaceuticals, Inc.'s total revenue?: ARS Pharmaceuticals, Inc. (SPRY) reported total revenue of $22.68M in Q1 2026.
How has ARS Pharmaceuticals, Inc.'s total revenue changed year-over-year?: ARS Pharmaceuticals, Inc.'s total revenue increased by 184.5% year-over-year, from $7.97M to $22.68M.
What is the long-term trend for ARS Pharmaceuticals, Inc.'s total revenue?: Over 4 years (2021 to 2025), ARS Pharmaceuticals, Inc.'s total revenue has grown at a 97.8% compound annual growth rate (CAGR), from $5.51M to $84.28M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.